Home > Publications database > Primary bone lymphoma: Clinical presentation and therapeutic considerations > print |
001 | 164035 | ||
005 | 20240229123203.0 | ||
024 | 7 | _ | |a 10.1016/j.jbo.2020.100326 |2 doi |
024 | 7 | _ | |a 2212-1366 |2 ISSN |
024 | 7 | _ | |a 2212-1374 |2 ISSN |
024 | 7 | _ | |a altmetric:92870822 |2 altmetric |
024 | 7 | _ | |a pmid:33083218 |2 pmid |
037 | _ | _ | |a DKFZ-2020-02203 |
082 | _ | _ | |a 610 |
100 | 1 | _ | |a Müller, Annika |b 0 |
245 | _ | _ | |a Primary bone lymphoma: Clinical presentation and therapeutic considerations |
260 | _ | _ | |a Amsterdam [u.a.] |c 2020 |b Elsevier |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1603447856_6074 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
536 | _ | _ | |a 315 - Imaging and radiooncology (POF3-315) |0 G:(DE-HGF)POF3-315 |c POF3-315 |f POF III |x 0 |
588 | _ | _ | |a Dataset connected to CrossRef |
700 | 1 | _ | |a Dreyling, Martin |b 1 |
700 | 1 | _ | |a Roeder, Falk |0 P:(DE-HGF)0 |b 2 |
700 | 1 | _ | |a Baur-Melnyk, Andrea |b 3 |
700 | 1 | _ | |a Knösel, Thomas |b 4 |
700 | 1 | _ | |a Klein, Alexander |b 5 |
700 | 1 | _ | |a Birkenmaier, Christof |b 6 |
700 | 1 | _ | |a Jansson, Volkmar |b 7 |
700 | 1 | _ | |a Dürr, Hans Roland |b 8 |
773 | _ | _ | |a 10.1016/j.jbo.2020.100326 |g Vol. 25, p. 100326 - |0 PERI:(DE-600)2695887-9 |p 100326 |t Journal of bone oncology |v 25 |y 2020 |x 2212-1374 |
909 | C | O | |o oai:inrepo02.dkfz.de:164035 |p VDB |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 2 |6 P:(DE-HGF)0 |
913 | 1 | _ | |a DE-HGF |l Krebsforschung |1 G:(DE-HGF)POF3-310 |0 G:(DE-HGF)POF3-315 |2 G:(DE-HGF)POF3-300 |v Imaging and radiooncology |x 0 |4 G:(DE-HGF)POF |3 G:(DE-HGF)POF3 |b Gesundheit |
914 | 1 | _ | |y 2020 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2020-01-16 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2020-01-16 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0320 |2 StatID |b PubMed Central |d 2020-01-16 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0501 |2 StatID |b DOAJ Seal |d 2020-01-16 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0500 |2 StatID |b DOAJ |d 2020-01-16 |
915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b DOAJ : Blind peer review |d 2020-01-16 |
915 | _ | _ | |a Creative Commons Attribution-NonCommercial-NoDerivs CC BY-NC-ND (No Version) |0 LIC:(DE-HGF)CCBYNCNDNV |2 V:(DE-HGF) |b DOAJ |d 2020-01-16 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2020-01-16 |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |d 2020-01-16 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2020-01-16 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2020-01-16 |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b J BONE ONCOL : 2018 |d 2020-01-16 |
915 | _ | _ | |a IF < 5 |0 StatID:(DE-HGF)9900 |2 StatID |d 2020-01-16 |
915 | _ | _ | |a Article Processing Charges |0 StatID:(DE-HGF)0561 |2 StatID |f 2020-01-16 |
915 | _ | _ | |a Fees |0 StatID:(DE-HGF)0700 |2 StatID |d 2020-01-16 |
920 | 1 | _ | |0 I:(DE-He78)E055-20160331 |k E055 |l E055 KKE Translationale Radioonkologie |x 0 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a I:(DE-He78)E055-20160331 |
980 | _ | _ | |a UNRESTRICTED |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|